New Delhi: The Serum Institute of India (SII), which produces the Covishield vaccine, is working on a vaccine for dengue, a viral infection transmitted by mosquitoes. Cyrus Poonawalla, the chairman of SII, said in a statement on Wednesday that the dengue vaccine will be ready in a year and will be effective against the disease. He also said that SII will soon introduce a vaccine for malaria, which will benefit not only India but also Africa, where malaria is prevalent.
Poonawalla said, “SII will be the first in the world to launch a malaria vaccine, after the success of Covishield. He said that malaria is a common infection in many parts of India. He also said that SII is developing a vaccine for dengue, which is another mosquito-borne disease. He said that the dengue vaccine will be available in a year. Both malaria and dengue are vector-borne diseases that are more common in tropical and subtropical regions. SII also made the Covishield vaccine after the outbreak of the Covid-19 pandemic.
A cancer vaccine is in the pipeline too!
Dengue and malaria affect millions of people every year during the rainy season, and some people die due to dengue. Therefore, Serum Institute’s scientists have been trying to find a vaccine to prevent these diseases for a long time. Scientists have now succeeded in making the vaccine. Serum scientists are also researching cancer, a serious disease. They are trying to find a vaccine for cancer too.